DNA methylation studies of depression with onset in the peripartum: A critical systematic review

Neurosci Biobehav Rev. 2019 Jul:102:106-122. doi: 10.1016/j.neubiorev.2019.04.005. Epub 2019 Apr 11.

Abstract

Objective: Major depression with peripartum onset (MDP) has been associated with multiple adverse offspring health outcomes. The biological mechanisms underlying this relationship remain unclear, but DNA methylation (DNAm) represents a plausible mechanism for mediating MDP exposures and changes in offspring development, behavior, and health. Advances in DNAm research necessitate reevaluating the MDP-DNAm literature to determine how well past studies conform with current best practices.

Method: Five databases were searched to identify studies of prenatal-onset MDP and DNAm. Quality scores were assigned to each article independently by two raters using a novel scale specific for MDP-DNAm research.

Results: Nineteen studies met inclusion criteria. Quality scores ranged from 10 to 17 out of 24 points (M = 12.8; SD = 1.9), with higher scores indicating increased study rigor. Poor covariate reporting was the most significant contributor to lower scores.

Conclusion: No longitudinal MDP-DNAm studies exist. Earlier MDP-DNAm studies should be interpreted with caution, and future research must commit to sharing methodology and data to facilitate cross-study comparisons and maximize dataset utility.

Keywords: DNA methylation; Epigenetics; Major depression; Pregnancy; Prenatal maternal depression; Reproducibility.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • DNA Methylation*
  • Depressive Disorder, Major*
  • Epigenomics*
  • Female
  • Humans
  • Peripartum Period*
  • Pregnancy
  • Pregnancy Complications*
  • Reproducibility of Results*